Status:
UNKNOWN
Effects of Multidisciplinary Intensive Targeted Care in Improving Diabetes Outcomes: a Pilot Study in Singapore
Lead Sponsor:
Changi General Hospital
Collaborating Sponsors:
Singapore General Hospital
Conditions:
Diabetes Mellitus, Type 2
Diabetic Nephropathy
Eligibility:
All Genders
21-70 years
Phase:
NA
Brief Summary
This study aims to investigate whether channeling purposefully structured resources to patients at high risk of developing diabetic complications to interdisciplinary team clinic consultations, inters...
Detailed Description
The prevalence of diabetes in Singapore is estimated to grow from 400,000 to 670,000 by 2030 and an alarming one million by 2050 with the continuing rise in obesity prevalence. The current system curr...
Eligibility Criteria
Inclusion
- Type 2 diabetic patients aged 21-70 years
- Poorly controlled diabetes with microalbuminuria as defined by the following HbA1C \> 9.0% with eGFR30- 60 ml/min and/or proteinuria \>0.5g/day and/or urine microalbumin:creatinine ratio \>300 mg/g on 2 consecutive measurements 3 months apart
Exclusion
- Type 1 diabetes defined as a history of ketosis at diagnosis \[acute symptoms with heavy ketonuria (\>3+) or ketoacidosis\] or continuous requirement of insulin within one year of diagnosis.
- Psychiatric conditions on medication
- On weight loss medications or have had bariatric surgery
- Life expectancy less than 12 months due to advanced cancers or other life-threatening conditions
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03413215
Start Date
March 1 2019
End Date
December 31 2022
Last Update
May 7 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Changi General Hospital
Singapore, Singapore, 529889